Impact of comorbidity on lung cancer mortality - a report from the Liverpool Lung Project

Oncology Letters
Michael W MarcusJohn K Field

Abstract

The aim of the present study was to apply the Charlson comorbidity index (CCI) to evaluate the impact of comorbidity on lung cancer mortality in individuals not exhibiting lung cancer at the commencement of follow-up. Data from 9,579 participants without lung cancer were extracted from the Liverpool Lung Project between 1999 and 2010 and linked to the Hospital Episode Statistics database. The occurrence of comorbidities was assessed one year prior to the individual inclusion date. CCI scores were computed and Cox regression analysis was used to evaluate the association between comorbidity and lung cancer mortality using a competitive risk approach. During a median follow-up of 11 years, 1,320/9,579 (13.7%) individuals developed lung cancer, of which 886 (67.1%) succumbed to lung cancer and 875 of the 9,579 individuals (9.1%) succumbed due to other causes. The severity of comorbidity was associated with higher lung cancer-specific mortality; low to moderate comorbidity exhibited a hazard ratio (HR) of 2.86 [95% confidence interval (CI), 1.17-7.02] and severe comorbidity exhibited an HR of 5.16 (95% CI, 2.07-12.89). Furthermore, the CCI score determined that the severity of comorbidity increased the risk of lung cancer-specific m...Continue Reading

References

Jan 9, 2001·Journal of Clinical Epidemiology·C N KlabundeJ L Warren
Feb 22, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R YancikB Conley
Feb 6, 2002·The Journal of Thoracic and Cardiovascular Surgery·Richard J BattafaranoG Alexander Patterson
Mar 2, 2002·Clinical Medicine : Journal of the Royal College of Physicians of London·J G Williams, R Y Mann
Jan 8, 2003·International Journal of Cancer. Journal International Du Cancer·C Martin TammemagiPaul Kvale
May 3, 2003·Journal of Clinical Epidemiology·Vincent de GrootLex M Bouter
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William L ReadJay F Piccirillo
Aug 12, 2004·British Journal of Cancer·J M SatagopanA D Auerbach
Dec 25, 2004·Journal of Clinical Epidemiology·Vijaya SundararajanWilliam A Ghali
Sep 15, 2005·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Ozcan BirimAd J J C Bogers
Sep 20, 2005·Journal of Clinical Epidemiology·C D'Arcy J HolmanJames B Semmens
Jan 27, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Haesook T Kim
Oct 6, 2007·Chest·Anthony J AlbergUNKNOWN American College of Chest Physicians
Jan 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy R AsmisUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Oct 22, 2008·Archives of Physical Medicine and Rehabilitation·Dan R BerlowitzW Bruce Vogel
Jun 6, 2009·American Journal of Epidemiology·Bryan LauStephen J Gange
Mar 23, 2010·The British Journal of Surgery·J N ArmitageUNKNOWN Royal College of Surgeons Co-morbidity Consensus Group
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Jan 11, 2011·American Journal of Clinical Oncology·Apar Kishor GantiAnne Kessinger
Jun 21, 2011·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Nov 8, 2011·Clinics in Chest Medicine·Charles S Dela CruzRichard A Matthay
Feb 23, 2012·British Journal of Cancer·T L JørgensenJ Herrstedt
Aug 30, 2012·Medical Care·Mansour T A SharabianiAlex Bottle
Oct 31, 2012·Lancet·Kirstin PirieUNKNOWN Million Women Study Collaborators

❮ Previous
Next ❯

Citations

Feb 7, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Marliese AlexanderDavid Ball
Apr 1, 2016·Lung Cancer Management·Angela Lin, Andrea Bezjak
May 15, 2018·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Jui-Kun ChiangYee-Hsin Kao

❮ Previous
Next ❯

Software Mentioned

Stata
SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
Pedro Enrique Jiménez CaballeroIgnacio Casado Naranjo
Respiration; International Review of Thoracic Diseases
Austin Chin Chwan NgLeonard Kritharides
International Urology and Nephrology
Manoch RattanasompattikulKamyar Kalantar-Zadeh
© 2021 Meta ULC. All rights reserved